CARBOPHAGE G2 TABLET is used to manage type 2 diabetes mellitus when diet, exercise and the single agent does not result in adequate glycemic control. It is a combination of Glimepiride and Metformin which belongs to a group of medicines called Antidiabetic agents. Glimepiride lowers blood sugar by causing the pancreas to produce more insulin and helps the body to use insulin efficiently. Metformin reduces the total amount of sugar released into the blood by the liver.

Along management with CARBOPHAGE G2 TABLET follow regular exercise and diet plan as advised by your doctor to achieve better results. Before taking CARBOPHAGE G2 TABLET inform your doctor if you have type 1 diabetes mellitus, diabetic ketoacidosis, severe liver or kidney disease, acute heart problems. Inform your doctor if you are pregnant or breastfeeding. It is not suitable for use in children and adolescents under 18 years of age.

Avoid consumption of alcohol during management with CARBOPHAGE G2 TABLET as it may increase or decrease the blood sugar lowering action of CARBOPHAGE G2 TABLET and increases the risk of lactic acidosis. The most common side effects of taking CARBOPHAGE G2 TABLET are taste disturbance, diarrhea or stomach ache. Contact your doctor if any of the symptoms worsen.